Evidence map›Paper›PMID 35011821›Full record

ArticleJournal of clinical medicine2021

ATOMS (Adjustable Transobturator Male System) Is an Effective and Safe Second-Line Treatment Option for Recurrent Urinary Incontinence after Implantation of an AdVance/AdVance XP Fixed Male Sling? A Multicenter Cohort Analysis.

Fabian Queissert, Keith Rourke, Sandra Schönburg, Alessandro Giammò, Andreas Gonsior, Carmen González-Enguita, Antonio Romero, Andres J Schrader, Francisco Cruz, Francisco E Martins and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fabian QueissertDepartment of Urology and Pediatric Urology, University of Münster, Schlosspl. 2, 48149 Münster, Germany.
Keith RourkeDepartment of Urology, Alberta University, 116 St. & 85 Ave., Edmonton, AB T6G 2R3, Canada.
Sandra SchönburgDepartment of Urology and Kidney Transplantation, Martin Luther University, Universitätsplatz 10, 06108 Halle (Saale), Germany.ORCID 0000-0002-1530-263X
Alessandro GiammòDepartment of Neuro-Urology, CTO/Spinal Cord Unit, AOU Città della Salute e della Scienza di Torino, Via Gianfranco Zuretti, 29, 10126 Torino, Italy.
Andreas GonsiorKlinik und Poliklinik für Urologie, University of Leipzig, Augustuspl. 10, 04109 Leipzig, Germany.
Carmen González-EnguitaDepartment of Urology, Hospital Universitario Fundación Jiménez Díaz, Av. de los Reyes Católicos, 2, 28040 Madrid, Spain.ORCID 0000-0002-5881-6614
Antonio RomeroDepartment of Urology, Hospital Universitario Morales Meseguer, Av. Marqués de los Vélez, s/n, 30008 Murcia, Spain.
Andres J SchraderDepartment of Urology and Pediatric Urology, University of Münster, Schlosspl. 2, 48149 Münster, Germany.
Francisco CruzCentro Hospitalar São João, Faculty of Medicine of Porto and i3S Institute, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Francisco E MartinsCentro Hospitalar Universitário de Lisboa Norte, Hospital Santa María, Av. Prof. Egas Moniz MB, 1649-028 Lisboa, Portugal.ORCID 0000-0002-5718-6964
Juan F DoradoPeRTICA Statistical Solutions, Av. Leonardo Da Vinci, 8, OF217, Getafe, 28906 Madrid, Spain.
Javier C AnguloClinical Department, Faculty of Biomedical Science, Universidad Europea de Madrid, Carretera de Toledo, Km 12.500, Getafe, 28905 Madrid, Spain.ORCID 0000-0002-1735-8792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: This study examined outcomes of second-line ATOMS implantation after failure of the fixed male sling (FMS) AdVance/AdVance XP. (2) Methods: A retrospective multicenter cohort analysis was carried out in men implanted with an ATOMS between 2011 and 2020 after failure of an AdVance/AdVance XP. Success was assessed on the basis of objective (dryness, 0-1 pad/24 h or >20 g/24 h pad test) and subjective results (PGI-I). We performed the Wilcoxon rank sum test, Fisher's exact test, logistic regression, and multivariate analysis. (3) Results: The study included 88 patients from 9 centers with a mean age of 71.3 years. No Clavien-Dindo > II complications occurred within the first 3 months after ATOMS implantation. A total of 10 cases (9%) required revision in the ensuing clinical course. After a mean follow-up of 42.5 months, 76.1% achieved social continence, and 56.8% used no pads at all. Mean urine leakage/24 h dropped from 422 g (3.9 pads) to 38 g (0.69 pads) and the mean ICIQ-SF decreased from 16.25 to 5.3 (

Indexed as

adjustable transobturator male systemartificial urinary sphincterfixed male slingsling failurestress urinary incontinence

Identifiers

PMID35011821
PMCPMC8745557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.